After growing up in the Netherlands and Germany, I graduated as a medical doctor in 2014, having tried to spend as much time possible traveling and seeing various different health care systems around the world. This also lead me to end up working in Denmark, where I enjoyed being a clinician for several years, until I was introduced and recruited to CSS. Here I am now allowed to see and participate in a different, yet just as exciting, side of medicine and surgery!

2015-2017: Resident, Department of Surgery, Herlev Hospital

2017-2018: Resident, Department of Obstetrics and Gynecology, Zealand University Hospital Roskilde

2018-2019: Resident, Department of Surgery, Zealand University Hospital Køge

2019-2021: Resident, Department of Surgery, Nordsjællands Hospital Hillerød

2021  – : PhD-student at Center for Surgical Science

2007-2014: Medicine, Ludwig-Maximilians Universität München

2010-2011: ERASMUS semester, Medicine, Université Pierre et Marie Curie, Paris, France

2011-2014: Clinical electives at Tygerberg Hospital (Cape Town, South Africa), Royal North Shore Hospital (Sydney, Australia), Vivantes Klinikum Friedrichshain (Berlin, Germany), The Royal Infirmary (Edinburgh, Scotland), Klinik Dr. Geisenhofer (Munich, Germany)

My research centers around inflammatory bowel disease (IBD) and surgery. I am currently preparing a clinical trial that focuses on patients with pouchitis, and helping to set up an IBD surgery database at Zealand University Hospital. This database will focus on identifying factors that influence the perioperative course of IBD patients, and will be a potential basis for future clinical trials. Furthermore, I am involved with the Big Data team from CSS, and helping to implement data from Danish Health registries into the OMOP Common Data model. While this currently focuses mainly on cancer-based research, I am aiming to utilize this work for building an IBD CDM that can be used for identifying risk factors and create prediction models in order to develop personalized medicine for patients with IBD.

  • “De novo donorspecific anti-HLA antibodies after kidney transplantation are associated with impaired graft outcome independently of their C1q-binding ability” Kauke T, Habicht A, Lin V, Oberhauser C, Coenene M, Fischereder M, Dick A, Schönermarck U, Guba M, Andrassy J, Meiser B, Angele M, Stangl M, Werner J Transplant International, November 2016 DOI: 10.1111/tri.12887
  • “ASO Author reflections: Does a Diagnosis of Ulcerative Colitis affect Outcome in Colorectal Cancer?” Lin V, Fransgaard T, Gögenur I Annals of Surgical Oncology, August 2021 DOI: 10.1245/s10434-021-10698-4
  • “Long-Term Outcomes After Colorectal Surgery in Patients with Ulcerative Colitis-Associated Colorectal Cancer Versus Sporadic Colorectal Cancer” Lin VA, Lohse R, Madsen MT, Fransgaard T, Remzi F, Gögenur I Annals of Surgical Oncology, August 2021 DOI: 10.1245/s10434-021-10759-8
  • “Training prediction models for individual risk assessment of postoperative complications after surgery for colorectal cancer” Lin VA, Tsouchnika A, Allakhverdiiev E, Rosen AW, Gögenur M, Clausen JSR, Bräunder KB, Walbech JS, Rijnbeek P, Drakos I, Gögenur I Techniques in coloproctology, May 2022 DOI: 10.1007/s10151-022-02624-x
  • “Developing prediction models for short-term mortality after surgery for colorectal cancer using a Danish national quality assurance database” Bräuner KB, Rosen AW, Tsouchnika A, Walbech JS, Gögenur M, Lin VA, Clausen JSR, Gögenur I International Journal of Colorectal Diseases, July 2022 DOI: 1007/s00384-022-04207-6
  • “Risk prediction for complications in Inflammatory Bowel Disease surgery: External validation of the American College of Surgeons’ National Surgical Quality Improvement Program Surgical Risk Calculator” Lin VA, Gögenur S, Pachler F, Fransgaard T, Gögenur I Journal of Crohn’s and Colitis, August 2022 DOI: 1093/ecco-jcc/jjac114


Forskning (keywords)

#Inflammatory bowel disease #surgery #colorectal cancer